These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 24621988)

  • 1. Direct reprogrammed neuronal cells as a novel resource for cell transplantation therapy.
    Yamashita T; Abe K
    Cell Transplant; 2014; 23(4-5):435-9. PubMed ID: 24621988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Regenerative therapy for post-stroke patients].
    Yamashita T; Abe K
    Nihon Rinsho; 2016 Apr; 74(4):661-5. PubMed ID: 27333756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integration-free reprogramming of human somatic cells to induced pluripotent stem cells (iPSCs) without viral vectors, recombinant DNA, and genetic modification.
    Heng BC; Fussenegger M
    Methods Mol Biol; 2014; 1151():75-94. PubMed ID: 24838880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induced pluripotency and direct reprogramming: a new window for treatment of neurodegenerative diseases.
    Li R; Bai Y; Liu T; Wang X; Wu Q
    Protein Cell; 2013 Jun; 4(6):415-24. PubMed ID: 23686735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induced pluripotent stem cells and their use in cardiac and neural regenerative medicine.
    Skalova S; Svadlakova T; Shaikh Qureshi WM; Dev K; Mokry J
    Int J Mol Sci; 2015 Feb; 16(2):4043-67. PubMed ID: 25689424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current status of treating neurodegenerative disease with induced pluripotent stem cells.
    Pen AE; Jensen UB
    Acta Neurol Scand; 2017 Jan; 135(1):57-72. PubMed ID: 26748435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progress and Challenges of Cell Replacement Therapy for Neurodegenerative Diseases Based on Direct Neural Reprogramming.
    Chen Y; Pu J; Zhang B
    Hum Gene Ther; 2016 Dec; 27(12):962-970. PubMed ID: 27589383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neural stem cell-based treatment for neurodegenerative diseases.
    Kim SU; Lee HJ; Kim YB
    Neuropathology; 2013 Oct; 33(5):491-504. PubMed ID: 23384285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of human induced pluripotent stem cells for modeling and treating neurodegenerative diseases.
    Payne NL; Sylvain A; O'Brien C; Herszfeld D; Sun G; Bernard CC
    N Biotechnol; 2015 Jan; 32(1):212-28. PubMed ID: 24815224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induced pluripotent stem cells in medicine and biology.
    Takahashi K; Yamanaka S
    Development; 2013 Jun; 140(12):2457-61. PubMed ID: 23715538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induced pluripotent stem (iPS) cells: a new source for cell-based therapeutics?
    de Lázaro I; Yilmazer A; Kostarelos K
    J Control Release; 2014 Jul; 185():37-44. PubMed ID: 24746625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Progress in induced pluripotent stem cell research for age-related neurodegenerative diseases].
    Ito D; Yagi T; Suzuki N
    Brain Nerve; 2013 Mar; 65(3):283-8. PubMed ID: 23475520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reprogramming of pericyte-derived cells of the adult human brain into induced neuronal cells.
    Karow M; Sánchez R; Schichor C; Masserdotti G; Ortega F; Heinrich C; Gascón S; Khan MA; Lie DC; Dellavalle A; Cossu G; Goldbrunner R; Götz M; Berninger B
    Cell Stem Cell; 2012 Oct; 11(4):471-6. PubMed ID: 23040476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reprogramming of somatic cells to induced neural stem cells.
    Shahbazi E; Mirakhori F; Ezzatizadeh V; Baharvand H
    Methods; 2018 Jan; 133():21-28. PubMed ID: 28939501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regeneration of the damaged central nervous system through reprogramming technology: basic concepts and potential application for cell replacement therapy.
    Matsui T; Akamatsu W; Nakamura M; Okano H
    Exp Neurol; 2014 Oct; 260():12-8. PubMed ID: 23036600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A combination of small molecules directly reprograms mouse fibroblasts into neural stem cells.
    Zheng J; Choi KA; Kang PJ; Hyeon S; Kwon S; Moon JH; Hwang I; Kim YI; Kim YS; Yoon BS; Park G; Lee J; Hong S; You S
    Biochem Biophys Res Commun; 2016 Jul; 476(1):42-8. PubMed ID: 27207831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reprogramming of adult human neural stem cells into induced pluripotent stem cells.
    Xie LQ; Sun HP; Wang T; Tang HL; Wang P; Zhu JH; Yao ZW; Feng XY
    Chin Med J (Engl); 2013 Mar; 126(6):1138-43. PubMed ID: 23506594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemically Induced Reprogramming of Somatic Cells to Pluripotent Stem Cells and Neural Cells.
    Biswas D; Jiang P
    Int J Mol Sci; 2016 Feb; 17(2):226. PubMed ID: 26861316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic potential of human induced pluripotent stem cells in experimental stroke.
    Chang DJ; Lee N; Park IH; Choi C; Jeon I; Kwon J; Oh SH; Shin DA; Do JT; Lee DR; Lee H; Moon H; Hong KS; Daley GQ; Song J
    Cell Transplant; 2013; 22(8):1427-40. PubMed ID: 23044029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential therapeutic applications of differentiated induced pluripotent stem cells (iPSCs) in the treatment of neurodegenerative diseases.
    Gao A; Peng Y; Deng Y; Qing H
    Neuroscience; 2013 Jan; 228():47-59. PubMed ID: 23069758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.